Memgen

Active Immune Therapy for Patients with Cancer

News & Events

Dr. Kipps Featured on Leukemia and Lymphoma Society Program on June 25

Published: June 9, 2008

Dr. Kipps, the inventor of Memgen's ISF35, will present an update on CLL therapy on Wed., June 25, 2008.

For more information:
Leukemia & Lymphoma Society Program Details